Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions

Sponsor
Gillette Children's Specialty Healthcare (Other)
Overall Status
Completed
CT.gov ID
NCT02428673
Collaborator
(none)
6
1
1
27.4
0.2

Study Details

Study Description

Brief Summary

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients.

This study will use load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome).

Hypothesis: Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.

Condition or Disease Intervention/Treatment Phase
  • Other: Assisted Standing Treatment Program
N/A

Detailed Description

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions such as cerebral palsy, spinal muscular atrophy, or other muscular dystrophies. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients.

Various modifications are added to assisted-standing devices to allow children with neuromuscular impairments to achieve standing postures. These customizations lead to load-sharing with the standing device, and consequently, a decrease in the amount of load passing through the lower extremities. Previous investigators developed custom-made load-measuring sensors to quantify the amount of load borne by the lower extremities while in passive standers, and found that the actual load varied from 23-102% of the child's body weight. These load-measuring sensors were specifically developed for restricted laboratory testing, rather than recording the load magnitude and duration of standing in any brand of standing device during daily use at home, school or therapy.

We previously developed load-sensing platforms that accurately measure loads experienced by the lower extremities of children with cerebral palsy in passive standers. These platforms can be incorporated into any stander design, are able to be used on a routine basis at a child's home, school or therapy, and are able to record the duration of weight-bearing to monitor compliance.

This study will use these load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome).

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions
Actual Study Start Date :
Dec 9, 2015
Actual Primary Completion Date :
Mar 23, 2018
Actual Study Completion Date :
Mar 23, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Load-measuring platform

A load-sensing platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device.

Other: Assisted Standing Treatment Program

Outcome Measures

Primary Outcome Measures

  1. Bone Mineral Density (BMD) (measured by DXA) [10 months]

    Change from baseline in BMD, as , at 10 months.

  2. Bone Architecture (measured by pQCT) [10 months]

    Change from baseline in bone architecture, as measured by pQCT, at 10 months.

Secondary Outcome Measures

  1. Pediatric Quality of Life Inventory (PedsQL) [10 months]

    Change from baseline in PedsQL scores at 10 months.

  2. Neuromuscular Module of the PedsQL [10 months]

    Change from baseline in PedsQL neuromuscular module scores at 10 months.

  3. Change in pulmonary function test [10 months]

    Change from baseline in pulmonary function at 10 months.

  4. Change in Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) [10 Months]

    Change from baseline in CPCHILD score at 10 months.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Must have a neuromuscular condition

  2. Must be between 3-14 years old

  3. Gross Motor Function Classification System (GMFCS) Level IV or V

  4. Must be on a standing treatment program

  5. Parent must be able to provide consent

Exclusion Criteria:
  1. Currently taking bisphosphonates

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gillette Children's Specialty Healthcare Saint Paul Minnesota United States 55101

Sponsors and Collaborators

  • Gillette Children's Specialty Healthcare

Investigators

  • Principal Investigator: Walter Truong, MD, Gillette Children's Specialty Healthcare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Walter Truong, Pediatric Orthopedic Surgeon, Gillette Children's Specialty Healthcare
ClinicalTrials.gov Identifier:
NCT02428673
Other Study ID Numbers:
  • Truong POSNA
First Posted:
Apr 29, 2015
Last Update Posted:
Feb 21, 2021
Last Verified:
Feb 1, 2021
Keywords provided by Walter Truong, Pediatric Orthopedic Surgeon, Gillette Children's Specialty Healthcare
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2021